Sheel Bio. — 360° view

Sheel Bio, a company in the Diversified Commercial Services industry, reported revenue of ₹51 crore and net profit of ₹3.00 crore for the September 2026 quarter.

Sheel Bio. (NSE: SHEEL-SM) closed at ₹57.90 on 20 Nov 2026, down 24.9% over the past year. Its market capitalisation is ₹118 crore and it trades at 7.9 times earnings.

Share price
₹57.90 (20 Nov 2026)
Market cap
₹118 Cr (20 Nov 2026)
P/E
7.86 (20 Nov 2026)
Revenue
₹51 Cr (September 2026 quarter)
Net profit
₹3 Cr (September 2026 quarter)
ROCE
13.5% (FY26)
ROE
11.2% (FY26)
Book value
₹64.1 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹81.00 / ₹37.80 (20 Nov 2026)
1-year return
-24.9% (to 20 Nov 2026)
Sector
Services
Industry
Diversified Commercial Services
Symbol
NSE: SHEEL-SM

Incorporated in November 1994, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.